ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) is struggling to gain traction with investors, as evidenced by its 1.84 million shares volume. The daily trading volume average remained 1.82 million shares over the course of 3 months. The stock had opened the regular trading at $4.13 and managed a 3.15% price change to reach $4.26 through the close.ZIOPHARM Oncology, Inc. (ZIOP) Analyst Opinion
ZIOPHARM Oncology, Inc. has a consensus outperform rating from 6 Wall Street analysts, and the number of shares currently sold short amount to at least 24.84% of shares outstanding. The stock spiked 1.43% last month and is up 2.9 this year. Wall Street is only getting more bullish on the stock, with 2 of analysts who cover ZIOP having a buy-equivalent rating. Analysts have placed a $12.5 price target on ZIOPHARM Oncology, Inc., suggesting a 193.43% gain from recent close. It’s currently trading about -45.94% below its 52-week high.
ZIOPHARM Oncology, Inc. (ZIOP) surprised the stock market in its last reported earnings when it earned -$0.13 a piece versus the consensus-estimated -$0.14. Its revenue totaled $1.62 million up 1.25% from the previous quarter.ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Intraday View
This stock (ZIOP) is ahead of its 52-week low with 13%. Its last month’s stock price volatility remained 6.33% which for the week stands at 6.03%. The share price has moved forward from its 20 days moving average, trading at a distance of 0.5% and stays -2.62% away from its 50 days moving average. Over the last five days, shares have faced -2.74% losses and now is down -25.45% since hitting its 200-day moving average of $5.34. ZIOPHARM Oncology, Inc. (ZIOP) has made its way to a 12-month decline of -21.26%.
Turning to Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY), its shares were trading at $46.2 a gain of $0.1, on the trading floor. The stock, after opening at $45.83, touched a high of $46.36 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.6. Dave & Buster’s Entertainment, Inc. has 4 buy ratings, 0 holds and 0 sells even after the stock tumbled -37.13% from its high of $73.48 to a $1.91 billion market value through last close.
The company’s consensus rating on Reuter’s scale remained unchanged from 1.6 to 1.6 during a month. Analysts set a 12-month price target of $74.61 a share. The target implies a 61.49% spike from where the shares are currently trading. Also, the current price highlights a discount of 105.63% to analysts’ high consensus price target.Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) Intraday Trading
The counter witnessed a trading volume of 2.24 million shares versus an average volume of 1.42 million shares during last trading session. Its last month’s stock price volatility remained 5.49% which for the week approaches 3.17%. The lowest price the stock reached in the last trading day was $44.79 and compares with the $43.77 52-week low. The stock recovered 5.55% since its low point and has performed -16.26% year-to-date.